These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Svrcek M; Cosnes J; Beaugerie L; Parc R; Bennis M; Tiret E; Fléjou JF Histopathology; 2007 Apr; 50(5):574-83. PubMed ID: 17394493 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Canavan C; Abrams KR; Mayberry J Aliment Pharmacol Ther; 2006 Apr; 23(8):1097-104. PubMed ID: 16611269 [TBL] [Abstract][Full Text] [Related]
8. [Colorectal cancer in inflammatory bowel disease]. Henriksen M; Moum B Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155 [TBL] [Abstract][Full Text] [Related]
9. Crohn's disease and colorectal carcinoma: rectal cancer complicating longstanding active perianal disease. Nikias G; Eisner T; Katz S; Levin L; Eskries D; Urmacher C; McKinley M Am J Gastroenterol; 1995 Feb; 90(2):216-9. PubMed ID: 7847288 [TBL] [Abstract][Full Text] [Related]
10. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397 [TBL] [Abstract][Full Text] [Related]
11. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease. Stange EF Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748 [TBL] [Abstract][Full Text] [Related]